 Proteomics International Laboratories Ltd ASX:PIQ has engaged global life science company Abcam plc LON:ABC OTCMKTS:ABCZF to manufacture reagents for the immunoassay version of its PromarkerD predictive blood test for the early detection of kidney disease in patients with type 2 diabetes. Abcam is a leader in the supply of life science research tools and reagents, including supply to those companies developing and marketing diagnostic solutions around the world. 